Prostate Cancer Patients May Benefit from New Fusion Biopsy Systems by UC-Care

Prostate Cancer Patients May Benefit from New Fusion Biopsy Systems by UC-Care
UC-Care and Axella BioVentures announced the introduction of the Navigo and SmartBx Systems, which they believe to offer the most advanced and accurate means of performing a prostate biopsy currently available, into medical practice in the United States. Navigo is a device that helps physicians to plan, place, image, and record prostate biospy samples in high-resolution 3-D. It fuses

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *